Documents
203 documents
Sort by:
Subscribe to the latest documents
- Date
- Relevance
-
Pharmacovigilance of biologicals - Lotte Minnema
Presentation of Lotte Minnema at the MEB Science Day 2021
-
GS-list 18
The list of active substances in products that may qualify for sale general sale (GS list) was updated by the MEB on 22 October ...
-
Terms and conditions for package fee and reduced fee for copy DCP application - human products
The term package fee entails that a group of products (each with an individual RVG number) is only billed once at the tariff ...
-
Summary - Report on paracetamol and PCA
-
Report on paracetamol and PCA
-
MEB 43: Two-round assessment policy for national procedures
Limiting the number of assessment rounds ensures that the (legally) stipulated time within which the MEB must make a decision ...
-
Strategic Business Plan 2020-2024
This Strategic Business Plan (SBP) describes the strategic direction of the Medicines Evaluation Board (MEB) in the coming period ...
-
MEB 13: Nomenclature of pharmaceutical products
This document describes the requirements which the marketing authorisation holder has to fulfil when submitting a proposal for a ...
-
MEB Science Day 2020 - Presentation Fiona Sewell
-
MEB Science Day 2020 - Presentation Coenraad Hendriksen